In vitro assessments of antimicrobial activity - task area a
Ended Awarded Last action
- Contract number
- 75N93019D00014
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $462,052 obligated
Award facts
- Opportunity
-
- RFPNIAIDDMIDNIHAI2017091 Solicitation number
- In Vitro Assessments of Antimicrobial Activity Award Notice · Posted Nov 14, 2017
- Combined order value
-
- $462,052 Current, with exercised options
- $1,275,123 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 2% used
- $30,000,000.00
- Maximum order
- $30,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 27 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded a $30 million Indefinite Delivery/Indefinite Quantity multiple-award contract to Southern Research Institute on January 11, 2019, with an ultimate completion date of January 14, 2026. This Indefinite Delivery contract, titled "In Vitro Assessments of Antimicrobial Activity" (IVAAA), was issued without set-aside designation and establishes a master contract vehicle for Southern Research to provide specialized antimicrobial testing and evaluation services. Southern Research, a tax-exempt non-profit research organization headquartered in Birmingham, Alabama, brings substantial expertise in infectious disease research and preclinical drug development, having previously held multiple large-value National Institute of Allergy and Infectious Diseases contracts exceeding $100 million in aggregate value. The contract is funded through the civilian National Institute of Allergy and Infectious Diseases, which supports research to understand, treat, and prevent infectious diseases.
Under this IVAAA master contract, Southern Research has received multiple delivery orders for in vitro antimicrobial assessments and therapeutic product evaluation. Task orders issued include a firm fixed-price delivery order awarded November 10, 2022, for antibacterial minimum inhibitory concentrations (MICs) testing of a gram-negative targeted compound collection, with work completed by April 6, 2023 in Birmingham, Alabama; and a cost-plus-fixed-fee delivery order valued at $1,275,123 awarded September 16, 2021, for evaluating therapeutic product candidates using bacterial in vitro hollow fiber models, completed by August 11, 2023 in Birmingham, Alabama. These task orders demonstrate the contract's focus on preclinical antimicrobial screening and efficacy assessment activities that support drug discovery and development initiatives aligned with National Institute of Allergy and Infectious Diseases research priorities.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93019D00014?
75N93019D00014 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 11, 2019.
How much is contract 75N93019D00014 worth?
Orders under 75N93019D00014 have obligated $462,052. Their combined potential value, with all options, is $1,275,123. 75N93019D00014's own ceiling is $30,000,000. A single order can be worth up to $30,000,000.
How many orders have been placed under contract 75N93019D00014?
2 orders have been placed under 75N93019D00014, the latest on November 10, 2022.
Who can order from contract 75N93019D00014?
75N93019D00014 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93019D00014 part of a contract vehicle?
Yes. 75N93019D00014 is part of In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93019D00014 competed?
The extent of competition for 75N93019D00014 was full and open competition. The government received 27 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV